Octapharma - Blood Disorder Treatment products (inc Haemophilia A & B)
The value below is a framework or dynamic market ceiling: the maximum
that could be spent across all call-offs, not the value of a single contract.
Aggregate figures on this site exclude these to avoid double counting.
key details
| Value | £71,550 |
|---|---|
| Status | complete |
| Category (CPV) | 33600000 |
| Region | East of England |
| Deadline | 31 Dec 2024 |
| Contract start | 1 Jan 2025 |
| Contract end | 30 Apr 2027 |
| Procedure | selective |
| SME suitable | No |
| OCID | ocds-b5fd17-1fa41b41-b7a5-488b-a97d-be850460433e |
Award
| Supplier | Value | Date | Status |
|---|---|---|---|
| Octapharma Limited | £71,550 | 1 Jan 2025 | active |
description
Call off contract/order from the NHS National Framework Agreement for the supply of products for the treatment of Blood Disorders including Haemophilia A & B.
Offer reference number: CM/PHS/22/5661
Specifically for products:
Fibryga Octaplas
notice history
1 notice published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 12 Mar 2025 | Award (award) | · | 10b5dbb7-eeb1-4711-b3b4-a963723a3283-833189 |
more from Norfolk and Norwich University Hospitals NHS Foundation Trust
- T&O Insourcing - pilot · 20 Jul 2026
- NNUH_Cambridge University Hospitals NHS Foundation Trust 2628 (HPV) · 16 Jul 2026
- NNUH_West Suffolk NHS Foundation Trust 2628 (HPV) · 13 Jul 2026
- NNUH_Frimley Health NHS Foundation Trust 2628 (HPV) · 8 Jul 2026
- NNUH - Secure IT - Data Centre Infrastructure Upgrade and Maintenance Contract · £98,667 · 1 Jul 2026
- Paediatric Audiology Insourcing · 2 Jun 2026
- Bausch & Lomb Phaco Procedure Packs & consumables · 2 Jun 2026
- Medtronic - Radio frequency ablation equipment and consumables · 2 Jun 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.